HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Charles G Eberhart Selected Research
Charles G Eberhart Research Topics
Disease
135
Neoplasms (Cancer)
06/2022 - 03/2002
62
Medulloblastoma
04/2022 - 08/2002
44
Glioma (Gliomas)
06/2022 - 03/2005
33
Glioblastoma (Glioblastoma Multiforme)
01/2021 - 10/2006
31
Brain Neoplasms (Brain Tumor)
03/2022 - 08/2002
18
Astrocytoma (Pilocytic Astrocytoma)
01/2019 - 07/2004
9
Carcinogenesis
01/2016 - 09/2002
8
Rhabdoid Tumor (Rhabdoid Tumors)
06/2022 - 02/2005
8
Hypoxia (Hypoxemia)
04/2022 - 09/2010
8
Carcinoma (Carcinomatosis)
08/2021 - 06/2006
7
Uveal melanoma
06/2022 - 02/2012
6
Retinoblastoma (Glioblastoma, Retinal)
06/2022 - 10/2016
5
Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2022 - 10/2007
5
Infections
06/2022 - 02/2005
5
Neoplasm Metastasis (Metastasis)
05/2019 - 03/2013
4
Cysts
12/2022 - 01/2013
4
Melanoma (Melanoma, Malignant)
01/2022 - 08/2014
4
Keratoconus
01/2020 - 05/2011
4
Primitive Neuroectodermal Tumors (PNET)
01/2019 - 06/2003
4
Meningioma (Meningiomas)
01/2019 - 10/2005
4
Fuchs' Endothelial Dystrophy
01/2014 - 02/2010
4
Alzheimer Disease (Alzheimer's Disease)
01/2014 - 09/2002
3
Inflammation (Inflammations)
12/2022 - 11/2015
3
Carcinoma in Situ
06/2022 - 12/2019
3
Hemorrhage
03/2021 - 11/2002
3
Retinal Detachment (Retinal Detachments)
01/2019 - 09/2012
3
Disease Progression
01/2018 - 01/2014
3
Diffuse Intrinsic Pontine Glioma
01/2017 - 06/2014
2
Papilloma (Papillomatosis)
06/2022 - 12/2021
2
Corneal Neovascularization
11/2020 - 01/2019
2
Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2020 - 01/2019
2
Pinealoma (Pineoblastoma)
05/2019 - 01/2018
Drug/Important Bio-Agent (IBA)
42
Proteins (Proteins, Gene)
FDA Link
03/2022 - 10/2003
20
Messenger RNA (mRNA)
IBA
01/2021 - 06/2003
19
DNA (Deoxyribonucleic Acid)
IBA
06/2022 - 02/2005
12
Formaldehyde (Formol)
FDA Link
06/2022 - 02/2011
12
Paraffin
IBA
06/2022 - 08/2010
12
Biological Products
IBA
01/2017 - 03/2004
11
Ligands
IBA
01/2019 - 03/2005
10
RNA (Ribonucleic Acid)
IBA
06/2022 - 05/2011
10
MicroRNAs (MicroRNA)
IBA
05/2019 - 04/2011
10
Transcription Factors (Transcription Factor)
IBA
01/2018 - 02/2008
9
Retinaldehyde (Retinal)
IBA
01/2021 - 07/2011
9
Pharmaceutical Preparations
IBA
01/2021 - 01/2010
9
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
11/2016 - 08/2006
8
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
06/2022 - 09/2008
8
Mechanistic Target of Rapamycin Complex 1
IBA
04/2022 - 12/2013
8
Biomarkers (Surrogate Marker)
IBA
03/2021 - 12/2008
7
Small Interfering RNA (siRNA)
IBA
06/2022 - 03/2005
7
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2021 - 09/2010
7
Phosphotransferases (Kinase)
IBA
01/2021 - 09/2008
7
Mitogen-Activated Protein Kinases
IBA
01/2021 - 01/2012
6
Protons (Proton)
IBA
03/2022 - 11/2013
6
Amides
IBA
03/2022 - 11/2013
6
Histones (Histone)
IBA
05/2019 - 04/2009
6
Oxygen (Dioxygen)
IBA
01/2017 - 09/2010
5
Temozolomide (Temodar)
FDA Link
Generic
06/2022 - 02/2013
5
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
03/2022 - 10/2013
5
TOR Serine-Threonine Kinases
IBA
01/2021 - 04/2005
5
Telomerase (Telomerase Reverse Transcriptase)
IBA
01/2019 - 06/2003
4
Glutamine (L-Glutamine)
FDA Link
03/2022 - 10/2019
4
Nucleotides
IBA
03/2022 - 10/2019
4
Cytokines
IBA
10/2021 - 09/2013
4
Matrix Metalloproteinases (MMPs)
IBA
01/2020 - 06/2006
4
Catenins
IBA
01/2019 - 12/2012
4
Chromatin
IBA
01/2018 - 12/2010
4
Antigens
IBA
01/2017 - 10/2003
4
dipinacoline glutamate
IBA
01/2017 - 09/2013
4
MRK 003
IBA
11/2016 - 02/2012
4
Digoxin (Digitek)
FDA Link
Generic
11/2015 - 09/2010
4
Enzymes
IBA
11/2013 - 10/2007
4
Polymers
IBA
02/2013 - 11/2002
4
cyclopamine
IBA
12/2010 - 08/2002
3
Steroids
IBA
12/2022 - 09/2012
3
Glutathione (Reduced Glutathione)
IBA
03/2022 - 01/2019
3
Glucose (Dextrose)
FDA Link
Generic
03/2022 - 01/2017
3
trametinib
IBA
01/2021 - 01/2018
3
Coloring Agents (Dyes)
IBA
11/2017 - 08/2006
3
Oligonucleotides
IBA
01/2016 - 07/2007
3
Lysine (L-Lysine)
FDA Link
06/2014 - 04/2009
3
Notch Receptors
IBA
02/2012 - 11/2004
3
beta Catenin
IBA
05/2004 - 09/2002
2
Fluorescein (Funduscein)
FDA Link
Generic
10/2022 - 01/2021
2
sapanisertib
IBA
04/2022 - 03/2016
2
Lipids
IBA
04/2022 - 01/2022
2
Glutamic Acid (Glutamate)
FDA Link
03/2022 - 03/2016
2
Keratins (Keratin)
IBA
12/2021 - 01/2013
2
Hypoxia-Inducible Factor 1
IBA
03/2021 - 02/2016
2
Hematoxylin (Haematoxylon)
IBA
01/2021 - 01/2017
2
Carboplatin (JM8)
FDA Link
Generic
01/2021 - 01/2019
2
Prodrugs
IBA
01/2021 - 10/2019
2
Eosine Yellowish-(YS) (Eosin)
IBA
01/2021 - 01/2017
2
Mitogens
IBA
01/2020 - 02/2015
2
Mucins
IBA
01/2020 - 06/2018
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2020 - 02/2008
2
Insulin-Like Peptides
IBA
01/2020 - 03/2011
Therapy/Procedure
44
Therapeutics
10/2022 - 07/2003
14
Drug Therapy (Chemotherapy)
01/2021 - 07/2004
8
Radiotherapy
01/2017 - 07/2004
4
Immunotherapy
12/2021 - 10/2003